Business Context and Reporting Period
Company: Intensity Therapeutics, Inc. (INTS)
Filing Type: Form 8-K (Current Report)
Date of Report: March 5, 2026
Reporting Period: The filing updates financial highlights through December 31, 2025.
The Company is an emerging growth company incorporated in Delaware. This report serves to update the investment community regarding a "Financial Highlights Slide" presented on March 5, 2026, which summarizes the Company's business and financial status for the year ended December 31, 2025.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document references an attached Exhibit 99.1 ("Financial Highlights Slide") containing these figures, but the text of the 8-K itself does not list them.
Important Note: All figures referenced in the associated slide are described as unaudited and preliminary. They are subject to completion of financial closing procedures and may differ materially from the final amounts reflected in the Company's audited financial statements for the year ended December 31, 2025.
Material Changes
The filing does not explicitly detail material changes versus prior periods within the text body. It indicates that the Company has updated its investor presentation materials to reflect the preliminary financial position as of December 31, 2025. Specific comparative data is contained within the referenced Exhibit 99.1, which is not included in the provided text.
Guidance, Outlook, and Risks
- Management Commentary: The Company distributes slides to the investment community to provide updates and summaries of its business.
- Unusual Items/Contingencies: The primary contingency noted is the preliminary nature of the data. The filing explicitly states that the amounts may differ materially from final financial statements due to ongoing closing procedures.
- Legal Status of Information: The information furnished in this Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that Section. It shall not be deemed incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the specific financial figures (revenue, cash position, burn rate) in the Exhibit 99.1 Financial Highlights Slide available on the Company's Investor Relations website, as these numbers are not in the 8-K text.
- Confirm the final audited financial statements for the year ended December 31, 2025, once filed, to reconcile any differences from these preliminary figures.
- Review the Company's status as an emerging growth company and its election regarding the extended transition period for new accounting standards.
- Note that the data is unaudited and subject to change.